BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ghafouri-Fard S, Gholipour M, Hussen BM, Taheri M. The Impact of Long Non-Coding RNAs in the Pathogenesis of Hepatocellular Carcinoma. Front Oncol 2021;11:649107. [PMID: 33968749 DOI: 10.3389/fonc.2021.649107] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Ghafouri-Fard S, Safarzadeh A, Hussen BM, Taheri M, Mokhtari M. Contribution of CRNDE lncRNA in the development of cancer and the underlying mechanisms. Pathol Res Pract 2023;244:154387. [PMID: 36893710 DOI: 10.1016/j.prp.2023.154387] [Reference Citation Analysis]
2 Habashy DA, Hamad MHM, Ragheb M, Khalil ZA, El Sobky SA, Hosny KA, Esmat G, El-ekiaby N, Fawzy IO, Abdelaziz AI. Regulation of IGF2BP1 by miR-186 and its impact on downstream lncRNAs H19, FOXD2-AS1, and SNHG3 in HCC. Life Sciences 2022;310:121075. [DOI: 10.1016/j.lfs.2022.121075] [Reference Citation Analysis]
3 Karunakara SH, Puttahanumantharayappa LD, Sannappa Gowda NG, Shiragannavar VD, Santhekadur PK. Novel Insights into MEG3/miR664a-3p/ADH4 Axis and Its Possible Role in Hepatocellular Carcinoma from an in Silico Perspective. Genes (Basel) 2022;13. [PMID: 36553522 DOI: 10.3390/genes13122254] [Reference Citation Analysis]
4 Braga EA, Fridman MV, Burdennyy AM, Filippova EA, Loginov VI, Pronina IV, Dmitriev AA, Kushlinskii NE. Regulation of the Key Epithelial Cancer Suppressor miR-124 Function by Competing Endogenous RNAs. IJMS 2022;23:13620. [DOI: 10.3390/ijms232113620] [Reference Citation Analysis]
5 Nagaraju GP, Dariya B, Kasa P, Peela S, El-Rayes BF. Epigenetics in hepatocellular carcinoma. Semin Cancer Biol 2022;86:622-32. [PMID: 34324953 DOI: 10.1016/j.semcancer.2021.07.017] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
6 Rusu I, Pirlog R, Chiroi P, Nutu A, Puia VR, Fetti AC, Rusu DR, Berindan-Neagoe I, Al Hajjar N. The Implications of Noncoding RNAs in the Evolution and Progression of Nonalcoholic Fatty Liver Disease (NAFLD)-Related HCC. Int J Mol Sci 2022;23:12370. [PMID: 36293225 DOI: 10.3390/ijms232012370] [Reference Citation Analysis]
7 Hao K, Li J, Zhang Y, Zhao W, Chen X, Xu J, Tian Y, Li X, Fen J, He X. Expression and prognostic signatures of m6A-related lncRNAs in hepatocellular carcinoma. J Cancer Res Clin Oncol 2022. [PMID: 36121511 DOI: 10.1007/s00432-022-04338-x] [Reference Citation Analysis]
8 Lu Q, Xin M, Guo Q, Rothberg BS, Gamero AM, Yang L. Knockdown of lncRNA TP53TG1 Enhances the Efficacy of Sorafenib in Human Hepatocellular Carcinoma Cells. ncRNA 2022;8:61. [DOI: 10.3390/ncrna8040061] [Reference Citation Analysis]
9 Huang Z, Liu S, Lu N, Xu L, Shen Q, Huang Z, Huang Z, Saw PE, Xu X. Nucleus‐specific RNAi nanoplatform for targeted regulation of nuclear lncRNA function and effective cancer therapy. Exploration. [DOI: 10.1002/exp.20220013] [Reference Citation Analysis]
10 Zhang W, Wu W, Meng Q, Yang L, Yuan J, Tian Z, Ding R, Zhang X, Wang J, Tao K. Research Progress on Long Noncoding RNAs and N6-Methyladenosine in Hepatocellular Carcinoma. Front Oncol 2022;12:907399. [DOI: 10.3389/fonc.2022.907399] [Reference Citation Analysis]
11 Wei W, Liu C, Wang M, Jiang W, Wang C, Zhang S. Prognostic Signature and Tumor Immune Landscape of N7-Methylguanosine-Related lncRNAs in Hepatocellular Carcinoma. Front Genet 2022;13:906496. [DOI: 10.3389/fgene.2022.906496] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
12 Chen Z, Qi L, Fu H, Ma L. Long non-coding RNA X-inactive specific transcript suppresses the progression of hepatocellular carcinoma through microRNA-221-3p-targeted regulation of O6-methylguanine-DNA methyltransferase. Bioengineered 2022;13:14013-27. [PMID: 35723009 DOI: 10.1080/21655979.2022.2086382] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Wang F, Zhu L, Xue Q, Tang C, Tang W, Zhang N, Dai C, Chen Z. Novel lncRNA AL033381.2 Promotes Hepatocellular Carcinoma Progression by Upregulating PRKRA Expression. Oxid Med Cell Longev 2022;2022:1125932. [PMID: 35035655 DOI: 10.1155/2022/1125932] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Karampa AD, Goussia AC, Glantzounis GK, Mastoridou EM, Anastasopoulos NT, Charchanti AV. The Role of Macroautophagy and Chaperone-Mediated Autophagy in the Pathogenesis and Management of Hepatocellular Carcinoma. Cancers (Basel) 2022;14:760. [PMID: 35159028 DOI: 10.3390/cancers14030760] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
15 Zhang Q, Jin D, Mou X, Ye H. PBMC CDC42 reveals the disease activity and treatment efficacy of TNF inhibitor in patients with ankylosing spondylitis. J Clin Lab Anal 2022;:e24267. [PMID: 35104386 DOI: 10.1002/jcla.24267] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Zhang S, Xu J, Cao H, Jiang M, Xiong J. KB-68A7.1 Inhibits Hepatocellular Carcinoma Development Through Binding to NSD1 and Suppressing Wnt/β-Catenin Signalling. Front Oncol 2022;11:808291. [DOI: 10.3389/fonc.2021.808291] [Reference Citation Analysis]
17 Yan J, Wan D. Dysregulation of circulating CDC42 and its correlation with demographic characteristics, comorbidities, tumor features, chemotherapeutic regimen and survival profile in non-small-cell lung cancer patients. J Clin Lab Anal 2021;:e24140. [PMID: 34952984 DOI: 10.1002/jcla.24140] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
18 Otmani K, Lewalle P. Tumor Suppressor miRNA in Cancer Cells and the Tumor Microenvironment: Mechanism of Deregulation and Clinical Implications. Front Oncol 2021;11:708765. [PMID: 34722255 DOI: 10.3389/fonc.2021.708765] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 8.0] [Reference Citation Analysis]
19 Lu Q, Guo Q, Xin M, Lim C, Gamero AM, Gerhard GS, Yang L. LncRNA TP53TG1 Promotes the Growth and Migration of Hepatocellular Carcinoma Cells via Activation of ERK Signaling. Noncoding RNA 2021;7:52. [PMID: 34564314 DOI: 10.3390/ncrna7030052] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
20 Wolinska E, Skrzypczak M. Epigenetic Changes Affecting the Development of Hepatocellular Carcinoma. Cancers (Basel) 2021;13:4237. [PMID: 34439391 DOI: 10.3390/cancers13164237] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
21 Liu Q, Cui W, Yang C, Du LP. Circular RNA ZNF609 drives tumor progression by regulating the miR-138-5p/SIRT7 axis in melanoma. Aging (Albany NY) 2021;13:19822-34. [PMID: 34370715 DOI: 10.18632/aging.203394] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]